1. Home
  2. SLS vs RMR Comparison

SLS vs RMR Comparison

Compare SLS & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • RMR
  • Stock Information
  • Founded
  • SLS 2012
  • RMR 1986
  • Country
  • SLS United States
  • RMR United States
  • Employees
  • SLS N/A
  • RMR 1000
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • SLS Health Care
  • RMR Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • RMR Nasdaq
  • Market Cap
  • SLS 233.7M
  • RMR 253.4M
  • IPO Year
  • SLS N/A
  • RMR N/A
  • Fundamental
  • Price
  • SLS $1.93
  • RMR $14.90
  • Analyst Decision
  • SLS Strong Buy
  • RMR
  • Analyst Count
  • SLS 1
  • RMR 0
  • Target Price
  • SLS $7.00
  • RMR N/A
  • AVG Volume (30 Days)
  • SLS 2.5M
  • RMR 87.9K
  • Earning Date
  • SLS 11-12-2025
  • RMR 11-10-2025
  • Dividend Yield
  • SLS N/A
  • RMR 12.04%
  • EPS Growth
  • SLS N/A
  • RMR N/A
  • EPS
  • SLS N/A
  • RMR 1.12
  • Revenue
  • SLS N/A
  • RMR $194,993,000.00
  • Revenue This Year
  • SLS N/A
  • RMR $323.25
  • Revenue Next Year
  • SLS N/A
  • RMR $1.07
  • P/E Ratio
  • SLS N/A
  • RMR $13.30
  • Revenue Growth
  • SLS N/A
  • RMR 1.73
  • 52 Week Low
  • SLS $0.77
  • RMR $13.48
  • 52 Week High
  • SLS $2.27
  • RMR $26.06
  • Technical
  • Relative Strength Index (RSI)
  • SLS 59.08
  • RMR N/A
  • Support Level
  • SLS $1.81
  • RMR N/A
  • Resistance Level
  • SLS $1.92
  • RMR N/A
  • Average True Range (ATR)
  • SLS 0.10
  • RMR 0.00
  • MACD
  • SLS 0.03
  • RMR 0.00
  • Stochastic Oscillator
  • SLS 87.67
  • RMR 0.00

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: